Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Tilray Brands's Pre-Tax Income for the
three
months ended in Feb. 2026 was €-19.7 Mil. Tilray Brands's Revenue for the
three
months ended in Feb. 2026 was €174.9 Mil. Therefore, Tilray Brands's pretax margin for the quarter that ended in Feb. 2026 was -11.25%.
The historical rank and industry rank for Tilray Brands's Pretax Margin % or its related term are showing as below:
WBO:TLR2'
s Pretax Margin % Range Over the Past 10 Years
Min: -280.33 Med: -29.25 Max: 97.13
Current: -169.76
WBO:TLR2's Pretax Margin % is ranked worse than 93.3% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs WBO:TLR2: -169.76
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Tilray Brands Pretax Margin % Related Terms
Tilray Brands Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Tilray Brands's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:TLR2 vs IRWD, BIOA, ESPR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tilray Brands Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Tilray Brands's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tilray Brands (WBO:TLR2) has a Pretax Margin % of -11.25% as of Feb. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #891 out of 955 companies in the Drug Manufacturers industry, placing it in the top 93.3%.
Is Tilray Brands' Pretax Margin % too high?
Tilray Brands' current Pretax Margin % is -11.25%. Based on the distribution chart, Tilray Brands ranks #891 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tilray Brands has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' Pretax Margin % compare to IRWD and BIOA?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #891 out of 955 companies for Pretax Margin %. This places Tilray Brands in the lower half of its industry. The industry median Pretax Margin % is 7.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current Pretax Margin % is -11.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (WBO:TLR2) is currently considered Possible Value Trap. The stock's GF Value™ is €10.82, compared to a current price of €3.92 — trading 63.8% below its estimated fair value. The current Pretax Margin % is -11.25%. Tilray Brands' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Tilray Brands (WBO:TLR2), the current Pretax Margin % is -11.25% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tilray Brands (WBO:TLR2) Overvalued in 2026?
Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued.
The current stock price of €3.92 is trading 63.8% below its estimated GF Value™ of €10.82.
GuruFocus considers Tilray Brands to be Possible Value Trap.
Key valuation signals for WBO:TLR2:
Pretax Margin %: -11.25%
GF Value™: €10.82 vs. price of €3.92 (63.8% below fair value)
No single metric tells the full story. See the WBO:TLR2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
55GF Score
Get the complete analysis for WBO:TLR2
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:TLR2 has been successfully added to your 
